Granted Patent B2

US 9,775,814 · App. 14/744,057 · Granted Oct 3, 2017

Abstract

Claims (46)

1. An oral enteric soft capsule shell formed from a gel mass composition comprising:

(a) at least one or more film-forming polymers comprising a Type A or a Type B gelatin;

(b) at least one or more acid-insoluble polymers comprising poly(methacylic acid-co-ethyl acrylate) 1:1 in an amount of about 8% to about 12% of the total gel mass;

(c) at least one or more plasticizers;

(d) a solvent; and

(e) optionally an alkali neutralizing-agent

wherein a ratio of the optional alkali neutralizing-agent to the acid-insoluble polymers is 1:14 to 1:3, and wherein a ratio of the gelatin to the acid-insoluble polymer(s) is 2.5:1 to 3:1.

2. The composition of claim 1 , wherein the one or more film-forming polymers comprises about 10% to about 40% of the total gel mass.

3. The composition of claim 1 , wherein the Type B gelatin comprises lime bone gelatin.

4. The composition of claim 1 , wherein the Type B gelatin has a Bloom strength of about 130 grams to about 170 grams.

5. The composition of claim 1 , wherein the Type B gelatin comprises about 20% to about 32% of the total gel mass.

6. The composition of claim 1 , wherein the one or more acid-insoluble polymers comprises about 5% to about 20% of the total gel mass.

7. The composition of claim 1 , wherein the one or more acid-insoluble polymers comprises acrylic and methacrylate acid copolymers, cellulose acetate phthalate (CAP), cellulose acetate butyrate, hydroxypropylmethylcellulose phthalate (HPMCP), sodium alginate, pectin, potassium alginate, or a combination thereof.

8. The composition of claim 1 , wherein the acid-insoluble polymer further comprises one or more acrylic and methacrylate acid copolymers comprising:

poly(ethyl acrylate-co-methyl methacrylate) 2:1 or

poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid) 7:3:1 or

combinations thereof.

9. The composition of claim 8 , wherein the weight ratio of poly(methacylic acid-co-ethyl acrylate) 1:1 to poly(ethyl acrylate-co-methyl methacrylate) 2:1 is about 1:1 to about 44:1.

10. The composition of claim 8 , wherein the weight ratio of poly(methacylic acid-co-ethyl acrylate) 1:1 to poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid) 7:3:1 is about 1:6 to about 5:1.

11. The composition of claim 8 , wherein poly(methacylic acid-co-ethyl acrylate) 1:1 comprises about 2% to about 15% of the total gel mass.

12. The composition of claim 8 , wherein poly(ethyl acrylate-co-methyl methacrylate) 2:1 comprises about 0.25% to about 4% of the total gel mass.

13. The composition of claim 8 , wherein poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid) 7:3:1 comprises about 1% to about 14% of the total gel mass.

14. The composition of claim 1 wherein the one or more plasticizers comprise sorbitol, non-crystallizing sorbitol, corn syrup, maltitol, glycerol, polyethylene glycol, citric acid, citric acid esters, triethyl citrate, or combinations thereof and wherein the total weight percentage of the one or more plasticizers comprises about 8% to about 30% of the total gel mass.

15. A method for preparing the enteric soft capsule according to claim 1 comprising:

(a) combining dry shell components comprising a gelatin composition and one or more acid-insoluble polymers together to form a dry mixture;

(b) adding plasticizer, solvent, and optionally an alkali neutralizing agent to the dry mixture with agitation to form a wet mixture;

(c) heating the wet mixture with agitation and applying vacuum deaeration to form a gel mass;

(d) heating the gel mass for an additional period;

(e) forming an enteric soft capsule using rotary die technology; and

(f) drying the enteric soft capsule.

16. The enteric soft capsule formed according to the method of claim 15 , wherein: (a) the gelatin composition comprises a Type A gelatin having a Bloom strength of about 175 to about 195 grams or a Type B gelatin having a Bloom strength of about 150 grams;

(b) the two or more acid-insoluble polymers comprises two or more of poly(methacrylic acid-co-ethyl acrylate) 1:1, and poly (ethyl acrylate-co-methyl methacrylate) 2:1, and/or poly (methyl acrylate-co-methyl methacrylate-co-methacrylic acid) 7:3:1;

(c) the one or more plasticizers comprise glycerol;

(d) the optional alkali neutralizing agent comprises sodium hydroxide; and

(e) the solvent comprises water.

17. An oral enteric soft capsule shell formed from a gel mass composition comprising:

(a) at least one or more film-forming polymers;

(b) at least two acid-insoluble polymers comprising poly(methacylic acid-co-ethyl acrylate) 1:1 and poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid) 7:3:1;

(c) at least one or more plasticizers; and

(d) a solvent,

wherein the ratio of poly(methacylic acid-co-ethyl acrylate) 1:1 to poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid) 7:3:1 is about 1:6 to about 5:1, and wherein a ratio of the film forming polymer to the acid-insoluble polymer(s) is 2.5:1 to 3:1.

18. The composition of claim 17 , wherein the two acid-insoluble polymers comprises about 5% to about 20% of the total gel mass.

19. The composition of claim 18 further comprising a non-volatile alkali neutralizing agent comprising sodium hydroxide or potassium hydroxide.

20. The composition of claim 18 , wherein the total weight percentage of the non-volatile alkali neutralizing agent comprises about 1% to about 7% of the total gel mass.

21. The composition of claim 17 , wherein the one or more film-forming polymers comprises Type A gelatin or Type B gelatin, wherein the Type A gelatin comprises acid bone, pig skin, poultry, fish, gelatin hydrolysate, or acid hide; and the Type B gelatin comprises lime bone gelatin.

22. The composition of claim 17 , wherein the ratio of poly(methacylic acid-co-ethyl acrylate) 1:1 to poly(methyl acrylate-co-methyl methacrylate-co-methacrylic acid) 7:3:1 is about 2:1 to about 3:1.

Assignments (10)